Cronobacter: An emerging opportunistic pathogen associated with neonatal meningitis, sepsis and necrotizing enterocolitis

Journal of Perinatology

Volumn 33, Issue 8, 2013, Pages 581-585

  Hunter, C J ^a,b   Bean, J F ^a  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cronobacter sakazakii; infant formula; meningitis; necrotizing enterocolitis; neonatal infections

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; CLINICAL FEATURE; CRONOBACTER; CRONOBACTER INFECTION; DISEASE ASSOCIATION; ENTEROBACTERIACEAE INFECTION; ENVIRONMENTAL EXPOSURE; HUMAN; INFECTION PREVENTION; INFECTION RISK; MENINGITIS; NECROTIZING ENTEROCOLITIS; NEONATAL MENINGITIS; NONHUMAN; PATHOGENESIS; SEPSIS; TREATMENT INDICATION;

ANTI-BACTERIAL AGENTS; CHILD; CRONOBACTER; ENTEROBACTERIACEAE INFECTIONS; ENTEROCOLITIS, NECROTIZING; FOOD MICROBIOLOGY; HUMANS; INFANT; INFANT FORMULA; INFANT, NEWBORN; MENINGITIS, BACTERIAL; OPPORTUNISTIC INFECTIONS; SEPSIS; STERILIZATION; VIRULENCE FACTORS;

EID: 84881176834     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2013.26     Document Type: Article

References (69)

1. Hunter CJ, Petrosyan M, Ford HR, Prasadarao NV. Enterobacter sakazakii: An emerging pathogen in infants and neonates. Surg Infect (Larchmt) 2008; 9: 533-539
2. Farmer 3rd JJ, Davis BR, Hickman-Brenner FW, McWhorter A, Huntley-Carter GP, Asbury MA et al. Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens. J Clin Microbiol 1985; 21: 46-76
3. Iversen C, Druggan P, Schumacher S, Lehner A, Feer C, Gschwend K et al. Development of a novel screening method for the isolation of 'Cronobacter' spp. (Enterobacter sakazakii). Appl Environ Microbiol 2008; 74: 2550-2553
4. Kucerova E, Clifton SW, Xia XQ, Long F, Porwollik S, Fulton L et al. Genome sequence of Cronobacter sakazakii BAA-894 and comparative genomic hybridization analysis with other Cronobacter species. PLoS One 2010; 5: E9556
5. Himelright I, Harris E, Lorch V, Anderson M, Jones T, Craig A et al. From the Centers for Disease Control and Prevention. Enterobacter sakazakii infections associated with the use of powdered infant formula-Tennessee, 2001. Jama 2002; 287: 2204-2205
6. Urmenyi AM, Franklin AW. Neonatal death from pigmented coliform infection. Lancet 1961; 1: 313-315
7. Iversen C, Mullane N, McCardell B, Tall BD, Lehner A, Fanning S et al. Cronobacter gen. nov., a new genus to accommodate the biogroups of Enterobacter sakazakii, and proposal of Cronobacter sakazakii gen. nov., comb. nov., Cronobacter malonaticus sp. nov., Cronobacter turicensis sp. nov., Cronobacter muytjensii sp. nov., Cronobacter dublinensis sp. nov., Cronobacter genomospecies 1, and of three subspecies, Cronobacter dublinensis subsp. dublinensis subsp. nov., Cronobacter dublinensis subsp. lausannensis subsp. nov. and Cronobacter dublinensis subsp. lactaridi subsp. nov. Int J Syst Evol Microbiol 2008; 58: 1442-1447
8. Friedemann M. Epidemiology of invasive neonatal Cronobacter (Enterobacter sakazakii) infections. Eur J Clin Microbiol Infect Dis 2009; 28: 1297-1304
9. Muytjens HL, Zanen HC, Sonderkamp HJ, Kollee LA, Wachsmuth IK, Farmer 3rd JJ. Analysis of eight cases of neonatal meningitis and sepsis due to Enterobacter sakazakii. J Clin Microbiol 1983; 18: 115-120
10. Block C, Peleg O, Minster N, Bar-Oz B, Simhon A, Arad I et al. Cluster of neonatal infections in Jerusalem due to unusual biochemical variant of Enterobacter sakazakii. Eur J Clin Microbiol Infect Dis 2002; 21: 613-616
11. Corti G, Panunzi I, Losco M, Buzzi R. Postsurgical osteomyelitis caused by Enterobacter sakazakii in a healthy young man. J Chemother 2007; 19: 94-96
12. Lai KK. Enterobacter sakazakii infections among neonates, infants, children, and adults. Case reports and a review of the literature. Medicine (Baltimore) 2001; 80: 113-122
13. Stoll BJ, Hansen N, Fanaroff AA, Lemons JA. Enterobacter sakazakii is a rare cause of neonatal septicemia or meningitis in VLBW infants. J Pediatr 2004; 144: 821-823
14. Simon M, Sabate S, Cristina Osanz A, Bartolome R. Dolores Ferrer M. [Investigation of a neonatal case of Enterobacter sakazakii infection associated with the use of powdered infant formula]. Enferm Infecc Microbiol Clin 2010; 28: 713-715
15. Flores JP, Medrano SA, Sanchez JS, Fernandez-Escartin E. Two cases of hemorrhagic diarrhea caused by Cronobacter sakazakii in hospitalized nursing infants associated with the consumption of powdered infant formula. J Food Prot 2011; 74: 2177-2181
16. Teramoto S, Tanabe Y, Okano E, Nagashima T, Kobayashi M, Etoh Y. A first fatal neonatal case of Enterobacter sakazakii infection in Japan. Pediatr Int 2010; 52: 312-313
17. Baumbach J, Rooney K, Smelser C, Torres P, Bowen A, Nichols M. Cronobacter species isolation in two infants-New Mexico, 2008. MMWR Morb Mortal Wkly Rep 2009; 58: 1179-1183
18. Bowen AB, Braden CR. Invasive Enterobacter sakazakii disease in infants. Emerg Infect Dis 2006; 12: 1185-1189
19. Reij MW, Jongenburger I, Gkogka E, Gorris LG, Zwietering MH. Perspective on the risk to infants in the Netherlands associated with Cronobacter spp. occurring in powdered infant formula. Int J Food Microbiol 2009; 136: 232-237
20. WHO. F. Enterobacter sakazakii (Cronobacter spp.) in powdered follow-up formulae: Meeting report 2008, [cited]Available from http://www.fao.org/ag/agn/ agns/jemra/Sakazakii-FUF-report.pdf
21. Gosney MA, Martin MV, Wright AE, Gallagher M. Enterobacter sakazakii in the mouths of stroke patients and its association with aspiration pneumonia. Eur J Intern Med 2006; 17: 185-188
22. Hunter CJ, Singamsetty VK, Chokshi NK, Camerini BoyleP, Grishin V, Upperman AV et al. Enterobacter sakazakii enhances epithelial cell injury by inducing apoptosis in a rat model of necrotizing enterocolitis. J Infect Dis 2008; 198: 586-593
23. Prasadarao NV, Wass CA, Weiser JN, Stins MF, Huang SH, Kim KS. Outer membrane protein A of Escherichia coli contributes to invasion of brain microvascular endothelial cells. Infect Immun 1996; 64: 146-153
24. Richardson AN, Lambert S, Smith MA. Neonatal mice as models for Cronobacter sakazakii infection in infants. J Food Prot 2009; 72: 2363-2367
25. Stephan R, Lehner A, Tischler P, Rattei T. Complete genome sequence of Cronobacter turicensis LMG 23827, a food-borne pathogen causing deaths in neonates. J Bacteriol 2011; 193: 309-310
26. Yan QQ, Condell O, Power K, Butler F, Tall BD, Fanning S. Cronobacter species (formerly known as Enterobacter sakazakii) in powdered infant formula: A review of our current understanding of the biology of this bacterium. J Appl Microbiol 2012; 113: 1-15
27. Nair MK, Venkitanarayanan K, Silbart LK, Kim KS. Outer membrane protein A (OmpA) of Cronobacter sakazakii binds fibronectin and contributes to invasion of human brain microvascular endothelial cells. Foodborne Pathog Dis 2009; 6: 495-501
28. Singamsetty VK, Wang Y, Shimada H, Prasadarao NV. Outer membrane protein A expression in Enterobacter sakazakii is required to induce microtubule condensation in human brain microvascular endothelial cells for invasion. Microb Pathog 2008; 45: 181-191
29. Prasadarao NV. Identification of Escherichia coli outer membrane protein A receptor on human brain microvascular endothelial cells. Infect Immun 2002; 70: 4556-4563
30. Pagotto FJ, Nazarowec-White M, Bidawid S, Farber JM. Enterobacter sakazakii: Infectivity and enterotoxin production in vitro and in vivo. J Food Prot 2003; 66: 370-375
31. Liu Q, Mittal R, Emami CN, Iversen C, Ford HR, Prasadarao NV. Human isolates of Cronobacter sakazakii bind efficiently to intestinal epithelial cells in vitro to induce monolayer permeability and apoptosis. J Surg Res 2012; 176: 437-447
32. Kim KP, Loessner MJ. Enterobacter sakazakii invasion in human intestinal Caco-2 cells requires the host cell cytoskeleton and is enhanced by disruption of tight junction. Infect Immun 2008; 76: 562-570
33. Hunter CJ, Podd B, Ford HR, Camerini V. Evidence vs experience in neonatal practices in necrotizing enterocolitis. J Perinatol 2008; 28(Suppl 1): S9-S13
34. Franco AA, Kothary MH, Gopinath G, Jarvis KG, Grim CJ, Hu L et al. Cpa, the outer membrane protease of Cronobacter sakazakii, activates plasminogen and mediates resistance to serum bactericidal activity. Infect Immun 2011; 79: 1578-1587
35. Emami CN, Mittal R, Wang L, Ford HR, Prasadarao NV. Recruitment of dendritic cells is responsible for intestinal epithelial damage in the pathogenesis of necrotizing enterocolitis by Cronobacter sakazakii. J Immunol 2011; 186: 7067-7079
36. Emami CN, Petrosyan M, Giuliani S, Williams M, Hunter C, Prasadarao NV et al. Role of the host defense system and intestinal microbial flora in the pathogenesis of necrotizing enterocolitis. Surg Infect (Larchmt) 2009; 10: 407-417
37. Kandhai MC, Reij MW, Gorris LG, Guillaume-Gentil O, van Schothorst M. Occurrence of Enterobacter sakazakii in food production environments and households. Lancet 2004; 363: 39-40
38. FSNET. Recalled baby formula found in Colorado stores. Colorado Department of Public Health and Environment 2002
39. Baumgartner A, Grand M, Liniger M, Iversen C. Detection and frequency of Cronobacter spp. (Enterobacter sakazakii) in different categories of ready-To-eat foods other than infant formula. Int J Food Microbiol 2009; 136: 189-192
40. Mramba F, Broce AB, Zurek L. Vector competence of stable flies, Stomoxys calcitrans L. (Diptera: Muscidae), for Enterobacter sakazakii. J Vector Ecol 2007; 32: 134-139
41. Chenu JW, Cox JM. Cronobacter ('Enterobacter sakazakii'): Current status and future prospects. Lett Appl Microbiol 2009; 49: 153-159
42. Clark NC, Hill BC, O'Hara CM, Steingrimsson O, Cooksey RC. Epidemiologic typing of Enterobacter sakazakii in two neonatal nosocomial outbreaks. Diagn Microbiol Infect Dis 1990; 13: 467-472
43. Muytjens HL, Roelofs-Willemse H, Jaspar GH. Quality of powdered substitutes for breast milk with regard to members of the family Enterobacteriaceae. J Clin Microbiol 1988; 26: 743-746
44. Iversen C, Forsythe S. Isolation of Enterobacter sakazakii and other Enterobacteriaceae from powdered infant formula milk and related products. Food Microbiology 2004; 21: 771-776
45. Chap J, Jackson P, Siqueira R, Gaspar N, Quintas C, Park J et al. International survey of Cronobacter sakazakii and other Cronobacter spp. in follow up formulas and infant foods. Int J Food Microbiol 2009; 136: 185-188
46. FDA. Investigation of Cronobacter Bacteria Illness in Infants [cited]Available from: Http://www.fda.gov/NewsEvents/PublicHealthFocus/ ucm285401.htm 2011
47. Alvarez-Ordonez A, Begley M, Hill C. Polymorphisms in rpoS and stress tolerance heterogeneity in natural isolates of Cronobacter sakazakii. Appl Environ Microbiol 2012; 78: 3975-3984
48. Arku B, Fanning S, Jordan K. Heat adaptation and survival of Cronobacter spp. (formerly Enterobacter sakazakii). Foodborne Pathog Dis 2011; 8: 975-981
49. Walsh D, Molloy C, Iversen C, Carroll J, Cagney C, Fanning S et al. Survival characteristics of environmental and clinically derived strains of Cronobacter sakazakii in infant milk formula (IMF) and ingredients. J Appl Microbiol 2011; 110: 697-703
50. Al-Nabulsi AA, Osaili TM, Al-Holy MA, Shaker RR, Ayyash MM, Olaimat AN et al. Influence of desiccation on the sensitivity of Cronobacter spp. to lactoferrin or nisin in broth and powdered infant formula. Int J Food Microbiol 2009; 136: 221-226
51. Edelson-Mammel SG, Buchanan RL. Thermal inactivation of Enterobacter sakazakii in rehydrated infant formula. J Food Prot 2004; 67: 60-63
52. Chen PC, Zahoor T, Oh SW, Kang DH. Effect of heat treatment on Cronobacter spp. in reconstituted, dried infant formula: Preparation guidelines for manufacturers. Lett Appl Microbiol 2009; 49: 730-737
53. Kim H, Ryu JH, Beuchat LR. Effectiveness of disinfectants in killing Enterobacter sakazakii in suspension, dried on the surface of stainless steel, and in a biofilm. Appl Environ Microbiol 2007; 73: 1256-1265
54. Kim H, Ryu JH, Beuchat LR. Survival of Enterobacter sakazakii on fresh produce as affected by temperature, and effectiveness of sanitizers for its elimination. Int J Food Microbiol 2006; 111: 134-143
55. Condell O, Iversen C, Cooney S, Power KA, Walsh C, Burgess C et al. Efficacy of biocides used in the modern food industry to control salmonella enterica, and links between biocide tolerance and resistance to clinically relevant antimicrobial compounds. Appl Environ Microbiol 2012; 78: 3087-3097
56. Adekunte A, Valdramidis VP, Tiwari BK, Slone N, Cullen PJ, Donnell CP et al. Resistance of Cronobacter sakazakii in reconstituted powdered infant formula during ultrasound at controlled temperatures: A quantitative approach on microbial responses. Int J Food Microbiol 2010; 142: 53-59
57. Arroyo C, Gayan E, Pagan R, Condon S. UV-C inactivation of Cronobacter sakazakii. Foodborne Pathog Dis 2012; 9: 907-914
58. Mahmoud BS. Inactivation effect of X-ray treatments on Cronobacter species (Enterobacter sakazakii) in tryptic soy broth, skim milk, low-fat milk and whole-fat milk. Lett Appl Microbiol 2009; 49: 562-567
59. Osaili T, Al-Nabulsi A, Shaker R, Ayyash M, Olaimat A, Abu Al-Hasan A et al. Effect of environmental stresses on the sensitivity of Enterobacter sakazakii in powdered infant milk formula to gamma radiation. Lett Appl Microbiol 2008; 47: 79-84
60. Hunter CJ, Williams M, Petrosyan M, Guner Y, Mittal R, Mock D et al. Lactobacillus bulgaricus prevents intestinal epithelial cell injury caused by Enterobacter sakazakii-induced nitric oxide both in vitro and in the newborn rat model of necrotizing enterocolitis. Infect Immun 2009; 77: 1031-1043
61. Al-Holy MA, Castro LF, Al-Qadiri HM. Inactivation of Cronobacter spp. (Enterobacter sakazakii) in infant formula using lactic acid, copper sulfate and monolaurin. Lett Appl Microbiol 2010; 50: 246-251
62. Quintero M, Maldonado M, Perez-Munoz M, Jimenez R, Fangman T, Rupnow J et al. Adherence inhibition of Cronobacter sakazakii to intestinal epithelial cells by prebiotic oligosaccharides. Curr Microbiol 2011; 62: 1448-1454
63. Gould DJ, Chudleigh JH, Moralejo D, Drey N. Interventions to improve hand hygiene compliance in patient care. Cochrane Database Syst Rev 2007, CD005186
64. El-Sharoud WM, O'Brien S, Negredo C, Iversen C, Fanning S, Healy B. Characterization of Cronobacter recovered from dried milk and related products. BMC Microbiol 2009; 9: 24
65. Kilonzo-Nthenge A, Rotich E, Godwin S, Nahashon S, Chen F. Prevalence and antimicrobial resistance of Cronobacter sakazakii isolated from domestic kitchens in middle Tennessee, United States. J Food Prot 2012; 75: 1512-1517
66. World Health Organization 2007, [cited] Available from: Http://www.who.int/ foodsafety/publications/micro/pif-guidelines.pdf
67. Centers for Disease Control. 2011 [cited] Available from: Http://www.cdc.gov/ media/releases/2011/s1230-Cronobacter.html
68. Food and Drug Administration 2007, [cited] Available from: Http://www.fda.gov/ ForConsumers/ConsumerUpdates/ucm048694.htm
69. Food and Drug Administration 2002, [cited] Available from: Http://www.fda.gov/ Safety/MedWatch/SafetyInformation/ SafetyAlertsforHumanMedicalProducts/ ucm154581.htm